Listen "Antigen validation and T-cell receptor engineering for cancer immunotherapies"
Episode Synopsis
This episode of the Talking Techniques podcast dives into the realm of cancer immunotherapies, focusing on antigen discovery and T-cell receptor engineering for T-cell therapies. Guiding us through the field is Jim Heath, President of the Institute for Systems Biology in Seattle, where he runs the Heath Lab, investigating fundamental immunology, and infectious and chronic diseases. Jim discusses the computational models and wet lab techniques he uses to characterize T cells, the importance of targeting a balanced immune response with immunotherapies and more in this podcast recorded at AACR 2024 (5th–10th April 2024; San Diego, CA, USA).Contents:Introductions: 00:00-02:00Intro to cancer vaccines and T-cell therapies: 02:00-04:00Antigen detection and validation in T-cell therapies: 04:00-05:20Wet lab and computational techniques for antigen detection: 05:20-09:15The importance of a balanced immune response to cancer immunotherapies: 09:15-10:30Technological developments in antigen detection: 10:30-13:45 Tips for best practice when conducting T-cell receptor design 13:45-15:40What is one thing you would like to see change in the field of antigen detection and T-cell receptor engineering? 15:40-16:30 Designing the path towards a more balanced immune response from immunotherapies 16:30-19:40 Hosted on Acast. See acast.com/privacy for more information.
More episodes of the podcast Talking Techniques
Cytokine networks in autoimmune diseases: mechanisms, pathogenesis and therapeutic innovations
19/06/2025
Cytokines: from therapeutics to diagnostics
10/07/2024
Rare disease and pharmacogenomics
23/01/2024
One man’s waste in another man’s treasure: using wastewater to monitor infectious diseases
18/12/2023
Next-generation antibody therapeutics
22/11/2023
CAR-T and CAR-NK cell therapies
27/07/2023
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.